04.26.18

Allergan Presents Data at the ARVO Annual Meeting in Honolulu

Source: Allergan
Allergan announced that 19 posters on their eye care offerings will be presented at this year’s ARVO meeting in Hawaii. These presentations will cover a variety of topics in various subspecialties, including ocular surface, glaucoma, and retina.
Retina Poster Presentations (Sunday, April 29th, 8:15AM-10:00AM)
  • Pegylation of Abicipar Increases Vitreal Half-Life, Supporting a Potential for up to 3-Month Duration of Action in the Clinic
    • Authors: Seal JR, et al.
  • In Vitro and In Vivo Characterization of Abicipar Pegol, an anti-VEGF DARPin® Therapeutic
    • Authors: Rodrigues GA, et al.
  • Simulation of Ocular Drug Distribution Following Zero Order Release of Intravitreally Dosed Bevacizumab Using 3D Computational Fluid Dynamic Model
    • Authors: Shen J, et al.
Glaucoma Poster Presentations
  • A Rabbit Model for Glaucoma Filtration Surgery
    • Authors: Nagar S, et al., Sunday, April 29th, 1:00PM-2:45PM
  • Patient-reported Outcomes of Bimatoprost Ocular Ring in an Open-label Extension Study in Patients with Open-angle Glaucoma or Ocular Hypertension
    • Authors: Chen M, et al., Monday, April 30th, 8:15AM-10:00AM
  • Intravitreal Brimonidine Drug Delivery System (Brimo DDS Generation 1) Enhances Spatial Sweep Visual Evoked Potential (sVEP) in a Nonhuman Primate Model of Chronic Glaucoma
    • Authors: Burke J, et al., Monday, April 30th, 8:15AM-10:00AM
  • In Vivo Angiographic Study of Rabbit Aqueous Outflow following Ab Interno Gelatin Stent Implantation
    • Authors: Lee SS, et al., Monday, April 30th, 11:15AM-1:00PM
  • Visualization of Conjunctival Lymphatic Vessels in Normotensive Rabbits
    • Authors: Rajagopalan L, et al., Monday, April 30th, 11:15AM-1:00PM
  • A Novel Iridocorneal Angle Measurement Technique: Assessment of Inter-and Intra-Scorer Variability
    • Authors: Nguyen A, et al., Monday, April 30th, 11:15AM-1:00PM
  • Complete Responders Following Ab Interno Gelatin Stent at 12M in Refractory Glaucoma Patients
    • Authors: Robinson MR, et al., Monday, April 30th, 3:30PM-5:15PM
  • Treatment Experience of Open Angle Glaucoma Patients Undergoing Trabeculectomy in the US
    • Authors: Patel A, et al., Wednesday, May 2nd, 3:30PM-5:15PM
  • Using a Novel Anterior Segment Optical Coherence Tomography (AS-OCT) Method to Assess Iridocorneal Angle
    • Authors: Goldberg J, et al., Thursday, May 3rd, 8:15AM-10:00AM
  • fMRI shows Functional Recovery by Intravitreal Brimonidine Drug Delivery System (Brimo DDS Generation 1) in a Rabbit Model of Retinal Ganglion Cell (RGC) Degeneration
    • Authors: Ghosn C, et al., Thursday, May 3rd, 11:00AM-12:45PM
Ocular Surface Treatment Poster Presentations
  • Effect of TrueTear on Dry Eye Symptoms During Exposure to a Controlled Adverse Environment
    • Authors: Senchyna M, et al., Sunday, April 29th, 3:15PM-5:00PM
  • The Repeatability of Tear Film Measurements in Subjects with Dry Eye
    • Authors: Stapleton F, et al., Sunday, April 29th, 3:15PM-5:00PM
  • Evaluation of the Durability of Dry Symptom Relief Following Daily Use of TrueTearTM
    • Authors: Penzner J, et al., Sunday, April 29th, 3:15PM-5:00PM
  • Changes in Tear Lipid Layer Thickness with Omega-3 Eye Drop
    • Authors: Fogt J, et al., Tuesday, May 1st, 3:30PM-5:15PM
  • Organic Osmolytes as Osmotic Agents vs. Salts in Artificial Tears
    • Authors: Liu H, et al., Wednesday, May 2nd, 11:15AM-1:00PM
  • Sodium Concentration Affects the Physical Properties of Hyaluronic Acid-based Lubricant Eye Drops
    • Authors: Simmons PA, et al., Wednesday, May 2nd, 11:15AM-1:00PM

Related Content